VANGUARD GROUP INC - NGM BIOPHARMACEUTICALS INC ownership

NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 123 filers reported holding NGM BIOPHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.3%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of NGM BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,954,378
-59.2%
2,761,102
-1.2%
0.00%
Q2 2023$7,234,544
-51.8%
2,793,260
-24.1%
0.00%
Q1 2023$15,008,374
-33.4%
3,678,523
-18.1%
0.00%
-100.0%
Q4 2022$22,535,528
-55.8%
4,489,149
+15.1%
0.00%
-50.0%
Q3 2022$51,003,000
+16.9%
3,899,297
+14.6%
0.00%
+100.0%
Q2 2022$43,629,000
-5.1%
3,403,208
+12.9%
0.00%0.0%
Q1 2022$45,971,000
-12.5%
3,014,475
+1.6%
0.00%0.0%
Q4 2021$52,550,000
+60.2%
2,967,237
+90.2%
0.00%0.0%
Q3 2021$32,794,000
+19.7%
1,560,125
+12.3%
0.00%0.0%
Q2 2021$27,392,000
-58.0%
1,389,074
-38.0%
0.00%
-50.0%
Q1 2021$65,160,000
+22.5%
2,241,448
+27.6%
0.00%0.0%
Q4 2020$53,206,000
+131.2%
1,756,261
+21.4%
0.00%
+100.0%
Q3 2020$23,014,000
-17.3%
1,446,537
+2.7%
0.00%0.0%
Q2 2020$27,812,000
+375.8%
1,408,979
+197.2%
0.00%
Q1 2020$5,845,000
-31.2%
474,007
+3.1%
0.00%
Q4 2019$8,500,000
+257.7%
459,709
+168.0%
0.00%
Q3 2019$2,376,000
-3.3%
171,544
+2.2%
0.00%
Q2 2019$2,457,000167,8490.00%
Other shareholders
NGM BIOPHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 3,766,666$59,928,00049.90%
Greenspring Associates, LLC 1,573,357$25,032,00038.95%
Svennilson Peter 18,017,932$286,665,00023.39%
Aquilo Capital Management, LLC 1,018,334$16,202,0001.72%
Jasper Ridge Partners, L.P. 308,750$4,912,0000.28%
Samsara BioCapital, LLC 36,451$580,0000.16%
Rock Springs Capital Management LP 360,454$5,735,0000.15%
Point72 Asset Management, L.P. 1,611,850$25,645,0000.13%
Virtus ETF Advisers LLC 14,880$237,0000.12%
WELD CAPITAL MANAGEMENT LLC 15,238$242,0000.10%
View complete list of NGM BIOPHARMACEUTICALS INC shareholders